Clinical Trial Update: Single Dose Study of the Effect of Formoterol Fumarate in Combination With Mometasone Furoate Inhaled Via a Pressurized Metered Dose Inhaler (pMDI) in Children Aged 5-11 Years Old With Persistent Asthma [Phase 2]

View source ↗

Summary

A Phase 2 single-dose study evaluated the combination inhaler of formoterol fumarate and mometasone furoate in children aged 5-11 with persistent asthma; the tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• FORMOTEROL FUMARATE (Formoterol fumarate dihydrate)
• Mometasone furoate inhalation (Mometasone furoate)

Snippet

Sponsor: Novartis | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2011-04-14